Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Alma
Alma Broekhuizen, Steenwijk NL
| Patent application number | Description | Published |
|---|---|---|
| 20120090181 | PERSONAL CARE APPARATUS - A personal care apparatus ( | 04-19-2012 |
Alma Dal Pozzo, Milan IT
| Patent application number | Description | Published |
|---|---|---|
| 20110160147 | NOVEL DUAL TARGETING ANTITUMORAL CONJUGATES - The present invention relates to dual-targeting cytotoxic compounds of formula (I) and to their preparation. The described compounds are endowed with tumour specific action, incorporating three functional units: a tumour recognition moiety and a tumour selective enzymatic substrate sequence connected together by means of a spacer. These conjugates are designed to guarantee serum stability and, at the same time, the desired action inside the tumour cells as a result of enzymatic cleavability. [(L-D) | 06-30-2011 |
Alma Dudia, Enschede NL
| Patent application number | Description | Published |
|---|---|---|
| 20120019833 | SYSTEM FOR ANALYSIS OF A FLUID - A system for analysis of a fluid, comprises a light source for radiating a beam of light an optical path for guiding at least part of the beam of light, a fluidic channel for guiding the fluid along the optical path, and a detector for detecting an optical characteristic of the light having propagated along the optical path. The optical path comprises a multimode interference structure, the multimode interference structure being arranged for providing a propagation of the beam of light in at least two propagation modes, the detector being positioned so as to receive light from each of the at least two propagation modes. | 01-26-2012 |
Alma Fulurija, Zurich-Schlieren CH
| Patent application number | Description | Published |
|---|---|---|
| 20100143392 | Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof - The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The present invention provides, inter alia, a composition comprising a virus-like particle (VLP) and at least one antigen, wherein said antigen is a GIP protein or a GIP fragment linked to the VLP respectively. | 06-10-2010 |
Alma Fulurija, Schlieren CH
| Patent application number | Description | Published |
|---|---|---|
| 20090028886 | Carrier conjugates of gnrh-peptides - The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising a virus like particle (VLP) and at least one GnRH peptide or fragment or variant thereof linked thereto. | 01-29-2009 |
Alma Gedvilaite, Vilnius LT
| Patent application number | Description | Published |
|---|---|---|
| 20090269371 | Process for the production of monoclonal antibodies - Provided is a use of a recombinant chimaeric protein as an immunogen in a process for producing a monoclonal antibody, wherein the recombinant chimaeric protein is assembled into a virus-like particles, and includes a foreign protein or peptide or a fragment thereof. | 10-29-2009 |
Alma Jaze, Astoria, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110242787 | FERRITE INDUCTORS INTEGRATED WITHIN INPUT/OUTPUT CABLE PORT ASSEMBLY OF AN ELECTRONICS RACK - An input/output cable port assembly and electromagnetic interference (EMI) attenuation method are provided. The port assembly includes a cable port structure for an electronics rack with an opening for input/output cables to pass therethrough, and a first and a second partition. The first and second partitions couple to the cable port structure and reside within the opening. The first partition includes at least one ferrite inductor portion and the second partition includes at least one second ferrite inductor portion. The partitions are configured to be disposed adjacent to each other as adjoining partitions within the cable port structure, and when disposed as adjoining partitions, the first and second ferrite inductor portions mate and define a ferrite inductor with a central opening for input/output cable(s) of the electronics rack to pass. The ferrite inductor attenuates electromagnetic interference resulting from transient or steady state currents on the cable(s) passing therethrough. | 10-06-2011 |
| 20110242788 | FERRITE INDUCTORS INTEGRATED WITHIN TOP-MOUNTED INPUT/OUTPUT CABLE PORT ASSEMBLY OF AN ELECTRONICS RACK - An input/output cable port assembly and electromagnetic interference attenuation method are provided. The cable port assembly includes a cable port structure mounted to an electronics rack with an opening for input/output cables to pass therethrough, and multiple bottom ferrite inductor portions and multiple top ferrite inductor portions. The bottom and top ferrite inductor portions include first and second surfaces, respectively. The inductor portions are configured to be stacked within the cable port structure with their first and second surfaces in opposing relation to define at least one ferrite inductor with a central opening defined by the first and second surfaces for input/output cable(s) of the electronics rack to pass. The ferrite inductor attenuates electromagnetic interference resulting from transient or steady state current on the cable(s) passing therethrough. | 10-06-2011 |
Alma Kasapovic, Vienna AT
| Patent application number | Description | Published |
|---|---|---|
| 20090188862 | COUNTER-PRESSURE FILTRATION OF PROTEINS - A method is disclosed for filtering a protein in a liquid mixture in a manner that does not substantially damage or otherwise limit the recovery of the protein in the filtration filtrate. The method generally includes passing a liquid mixture containing a protein (e.g., an aqueous vWF mixture) through a filter while applying a counter pressure to the liquid mixture filtrate to accurately reduce and control the pressure differential across the filter. The disclosed method has the advantage that relatively high filtration flow rates can be achieved at relatively low pressure differentials, in contrast to high pressure differentials, which actually reduce the filtration flow rate of protein liquid mixtures. Further, the method can recover substantially all of the protein that is initially present in the liquid mixture. | 07-30-2009 |
| 20100314317 | Counter-Pressure Filtration of Proteins - A method is disclosed for filtering a protein in a liquid mixture in a manner that does not substantially damage or otherwise limit the recovery of the protein in the filtration filtrate. The method generally includes passing a liquid mixture containing a protein (e.g., an aqueous vWF mixture) through a filter while applying a counter pressure to the liquid mixture filtrate to accurately reduce and control the pressure differential across the filter. The disclosed method has the advantage that relatively high filtration flow rates can be achieved at relatively low pressure differentials, in contrast to high pressure differentials, which actually reduce the filtration flow rate of protein liquid mixtures. Further, the method can recover substantially all of the protein that is initially present in the liquid mixture. | 12-16-2010 |
| 20100317081 | Counter-Pressure Filtration of Proteins - A method is disclosed for filtering a protein in a liquid mixture in a manner that does not substantially damage or otherwise limit the recovery of the protein in the filtration filtrate. The method generally includes passing a liquid mixture containing a protein (e.g., an aqueous vWF mixture) through a filter while applying a counter pressure to the liquid mixture filtrate to accurately reduce and control the pressure differential across the filter. The disclosed method has the advantage that relatively high filtration flow rates can be achieved at relatively low pressure differentials, in contrast to high pressure differentials, which actually reduce the filtration flow rate of protein liquid mixtures. Further, the method can recover substantially all of the protein that is initially present in the liquid mixture. | 12-16-2010 |
Alma Ortiz Vela, Cuautitlan Izcalli MX
| Patent application number | Description | Published |
|---|---|---|
| 20100056422 | FRAGRANCE DISPENSER - The invention proposes a fragrance dispenser, comprising a first and a second carrier, each carrier comprising one or more fragrance substances, wherein the fragrance substances comprise one or more fragrance substances a) with a vapour pressure of at least 0.1 mmHg at 25° C. (“HVA”) and one or more fragrance substances b) with a vapour pressure of less than 0.1 mmHg at 25° C. (“LVA”), and wherein the fragrance substances are distributed to the first and second carrier such that at least 80 wt.-% of all HVA fragrance substances are carried by the first carrier. | 03-04-2010 |
Alma Riska, Mars, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090132754 | DATA STORAGE DEVICE WITH HISTOGRAM OF IDLE TIME AND SCHEDULING OF BACKGROUND AND FOREGROUND JOBS - A data storage device includes a cumulative data histogram of lengths of idle times between foreground user service requests. The cumulative data histogram is updated with measured lengths of current idle times between successive user service requests. Background service request are scheduled following a user service request after a time delay that is controlled as a function of the cumulative data histogram and a calculated length of a busy time of the background service request. | 05-21-2009 |
Alma Zernecke, Aachen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110044988 | METHODS OF TREATMENT USING ANTI-MIF ANTIBODIES - Disclosed herein, in certain embodiments, is a method for treating an inflammatory disorder. In some embodiments, the method comprises administering an active agent that inhibits (i) MIF binding to CXCR2 and CXCR4 and/or (ii) MIF-activation of CXCR2 and CXCR4; (iii) the ability of MIF to form a homomultimer; or a combination thereof. | 02-24-2011 |
| 20110070184 | METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS AND RELATED CONDIDTIONS - Described herein are methods for treating or preventing a atherosclerosis by inhibiting the activation or binding of macrophage migration inhibitory factor to CXCR2 and CXCR4. Such inhibition is achieved by administration of either a single agent or a combination of agents. Also described herein are agents that inhibit MIF-binding or MIF-activation of CXCR2 or CXCR4. Further described are pharmaceutical compositions comprising such agents and their use for treating or preventing atherosclerosis. | 03-24-2011 |
| 20110262386 | METHODS OF TREATING INFLAMMATION - Disclosed herein, in certain embodiments, is a method for treating an MIF-mediated disorder. In some embodiments, the method comprises administering an active agent that inhibits (i) MIF binding to CXCR2 and CXCR4 and/or (ii) MIF-activation of CXCR2 and CXCR4; (iii) the ability of MIF to form a homomultimer; or a combination thereof. | 10-27-2011 |